David Grainger
Chief Scientific Advisor
London, England, United Kingdom
27 investmentsDavid Grainger is a Chief Scientific Advisor based in London, England, United Kingdom. David Grainger has backed 27 companies, including Gadeta, SuperX and Critical Pressure. Investment focus areas include Health Care, Hospitals and Delivery Service.
Sign up to access email, LinkedIn & portfolio
Investment Focus
Portfolio Companies (27)
| Industry | Stage | Website | |||
|---|---|---|---|---|---|
| 1 | Gadeta | — | — | — | — |
| 2 | SuperX | — | — | — | — |
| 3 | Critical Pressure | — | — | — | — |
| 4 | Impact Biomedicines | — | — | — | — |
| 5 | Inexia | — | — | — | — |
| 6 | Aura Biosciences | — | — | — | — |
| 7 | Janpix | — | — | — | — |
| 8 | Alderaan Biotechnology | — | — | — | — |
| 9 | ApcinteX | — | — | — | — |
| 10 | Yukin Therapeutics | — | — | — | — |
| 11 | Xenikos | — | — | — | — |
| 12 | Palladio Biosciences | — | — | — | — |
Showing 1–12 of 27
Page 1 of 3
Access Full Contact Information
Get David Grainger's email, LinkedIn, Twitter, full portfolio of investments, and export data to CSV.
Email
LinkedIn
Portfolio
No credit card required
Raising a round? Run your numbers first
Free tools founders use before pitching investors like this one.